{
    "title": "Novo Nordisk eyes 2022 sales growth of 6% to 10%",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10467159/Novo-Nordisk-eyes-2022-sales-growth-6-10.html",
    "date": "2022-02-02",
    "keywords": [
        "operating",
        "profit",
        "drug",
        "growth",
        "novo",
        "year",
        "nordisk",
        "wednesday",
        "share",
        "demand",
        "half",
        "copenhagen",
        "fourthquarter",
        "developer",
        "increase",
        "period",
        "average",
        "refinitiv",
        "poll",
        "progress",
        "executive",
        "joergensen",
        "statement",
        "quarter",
        "company",
        "dividend",
        "buyback",
        "program",
        "supply",
        "obesity",
        "prospect",
        "wegovy",
        "place",
        "analyst",
        "hansen",
        "note",
        "skydsgaard",
        "editing",
        "clarence",
        "fernandez",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}